A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

August 23, 2021

Study Completion Date

October 25, 2021

Conditions
Alzheimer Disease (AD)
Interventions
DRUG

Zagotenemab

Administered IV

DRUG

Placebo

Administered IV

Trial Locations (60)

18104

Lehigh Center for Clinical Research, Allentown

19063

Suburban Research Associates, Media

21208

Pharmasite Research, Inc., Baltimore

22031

Cognition Health, Fairfax

27103

PMG Research of Winston-Salem, LLC, Winston-Salem

27607

Raleigh Neurology Associates, P.A., Raleigh

31909

Columbus Memory Center, PC, Columbus

32127

Progressive Medical Research, Port Orange

32806

BioClinica Inc, Orlando

33024

Infinity Clinical Research, LLC, Hollywood

33064

Quantum Laboratories Clinical Research, Deerfield Beach

33176

VIN-Victor Faradji, Miami

33180

Julie B. Schwartzbard, MD, PA, Aventura

33351

Infinity Clinical Research, LLC, Sunrise

33445

Brain Matters Research, Delray Beach

33462

JEM Research Institute, Atlantis

33912

Neuropsychiatric Research Center of Southwest Florida, Fort Myers

34470

Renstar Medical Research, Ocala

34997

Brain Matters Research, Stuart

43210

Ohio State University Medical Center, Columbus

45219

Lindner Research Center, Cincinnati

45417

University of Cincinnati Health Neurology, Dayton

46256

Josephson Wallack Munshower Neurology, PC, Indianapolis

60007

AMITA Health - Alexian Brothers Neurosciences Institute Clinical Research, Elk Grove Village

60640

Great Lakes Clinical Trials, Chicago

63005

Clinical Research Professionals, Chesterfield

66214

Rowe Neurology Institute, Lenexa

66606

Cotton O'Neil Clinic, Topeka

75231

Baylor AT&T Memory Center, Dallas

75243

Neurology Consultants of Dallas, PA, Dallas

77030

Houston Methodist Research Ins, Houston

85006

Banner Alzheimer's Institute, Phoenix

85718

Center for Neurosciences, Tucson

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

91402

National Research Institute - Huntington Park, Panorama City

92103

Pacific Research Network, San Diego

92374

Anderson Clinical Research, Redlands

92614

Irvine Clinical Research Center, Irvine

92705

Syrentis Clinical Research, Santa Ana

92835

Fullerton Neurology and Headache Center, Fullerton

94158

Univ of California San Francisco, San Francisco

4748511

National Center for Geriatrics and Gerontology, Ōbu

06905

New England Institute for Clinical Research, Stamford

02111

Tufts Medical Center, Boston

02459

Boston Center for Memory, Newton

07081

The Cognitive and Research Center of New Jersey, Springfield

08755

Advanced Memory Research Institute of New Jersey, Toms River

02906

Butler Hospital, Providence

05201

The Memory Clinic, Bennington

K9H 2P4

Kawartha Centre - Redefining Healthy Aging, Peterborough

M3B2S7

Toronto Memory Program, Toronto

J8T 8J1

Clinique de la Mémoire de l'Outaouais, Gatineau

J4V 2J2

NeuroSearch Developements, Greenfield Park

J1J 2G2

Q&T Research Sherbrooke Inc., Sherbrooke

650-0046

Kobe City Medical Center General Hospital, Kobe

113-8603

Nippon Medical School Hospital, Tokyo

616-8255

National hospital Organization Utano National Hospital, Kyoto

710-0813

Katayama Medical Clinic, Kurashiki

247-8533

Shonan Kamakura General Hospital, Kamakura

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03518073 - A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease | Biotech Hunter | Biotech Hunter